References
- 1. J. E. Cohen, P. Atluri, M. D. Taylor, T. J. Grand, G. P. Liao, C. M. Panlilio, E. E. Suarez, S. E. Zentko, V. M. Hsu, M. F. Berry, M. J. Smith, T. J. Gardner, H. L. Sweeney and Y. J. Woo, Fructose 1,6-diphosphate administration attenuates post-ischemic ventricular dysfunction, Heart Lung Circ. 15 (2006) 119-123; DOI: 10.1016/j.hlc.2005.12.004.
- 2. L. Galzigna, V. Rizzoli, M. Bianchi, M. P. Rigobello and R. Scuri, Some effects of fructose-1,6-diphosphate on rat myocardial tissue related to a membrane-stabilizing action, Cell Biochem. Funct. 7 (1989) 91-96; DOI: 10.1002/cbf.290070203.
- 3. B. Tavazzi, L. Cerroni, D. D. Pierro, G. Lazzarino, M. Nuutinen, J. W. Starnes and B. Giardina, Oxygen radical injury and loss of high-energy compounds in anoxic and reperfused rat heart: prevention by exogenous fructose-1,6-bisphosphate, Free Radic. Res. 10 (1990) 167-176; DOI: 10.3109/10715769009149885.
- 4. A. K. Markov, Hemodynamics and metabolic effects of fructose 1,6-diphosphate in ischemia and shock-experimental and clinical observations, Ann. Emerg. Med. 15 (1986) 1470-1477; DOI: 10.1016/ S0196-0644(86)80946-5.
- 5. X. T. Wu, J. S. Li, X. F. Zhao, N. Li, Y. K. Ma, W. Zhuang, Y. Zhou and G. Yang, Effects of n-3 fatty acid, fructose-1,6-diphosphate and glutamine on mucosal cell proliferation and apoptosis of small bowel graft after transplantation in rats, World J. Gastroenterol. 9 (2003) 1323-1326.
- 6. T. J. Wheeler, J. M. McCurdy and S. Chien, Permeability of fructose-1,6-bisphosphate in liposomes and cardiac myocytes, Mol. Cell Biochem. 259 (2004) 105-114; DOI: 10.1023/B:MCBI.0000021356.89867.0d.
- 7. T. Kaakinen, A. Naukkarinen, H. Tuominen, P. Romsi, M. Nuutinen, F. Biancari and T. Juvonen, Neuronal ultrastructure is preserved by fructose-1,6-bisphosphate after hypothermic circulatory arrest in pigs, J. Thorac. Cardiov. Sur. 130 (2005) 1475-1476; DOI: 10.1016/j.jtcvs.2005.07.037.
- 8. R. Didlake, K. A. Kirchner, J. Lewin, J. D. Bower and A. K. Markov, Attenuation of ischemic renal injury with fructose 1,6-diphosphate, J. Surg. Res. 47 (1989) 220-226; DOI: 10.1016/0022-4804(89)90111-X.
- 9. N. Antunes, C. A. Martinusso, C. M. Takiya, A. J. Silva, J. F. Ornellas, P. R. Elias, M. Leite, Jr. and L. R. Cardoso, Fructose-1,6-diphosphate as a protective agent for experimental ischemic acute renal failure, Kidney Int. 69 (2006) 68-72; DOI: 10.1038/sj.ki.5000013.
- 10. K. Xu and J. L. Stringer, Pharmacokinetics of fructose-1, 6-diphosphate after intraperitoneal and oral administration to adult rats, Pharmacol. Res. 57 (2008) 234-238; DOI 10.1016/j.phrs.2008.01.008.
- 11. S. Drabant, I. Klebovich, B. Gachalyi, G. Renczes and C. Farsang, Role of food interaction pharmacokinetic studies in drug development. Food interaction studies of theophylline and nifedipine retard and buspirone tablets, Acta Pharm. Hung. 68 (1998) 294-306.
- 12. C. S. Won, N. H. Oberlies and M. F. Paine, Mechanisms underlying food-drug interactions: inhibition of intestinal metabolism and transport, Pharmacol. Ther. 136 (2012) 186-201. DOI: 10.1016/j. pharmthera.2012.08.001.
- 13. L. Yunxia, L. Hongye, X. H. Jiang and C. Peng, Assessment and modulation of phillyrin absorption by P-gp using Caco-2 cells and MDR1-MDCKII cells, Eur. J. Drug Metab. Ph. 36 (2011) 41-47; DOI: 10.1007/s13318-011-0026-0.
- 14. P. Artursson and J. Karlsson, Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells, Biochem. Bioph. Res. Co. 175 (1991) 880-885; DOI: 10.1016/0006-291X(91)91647-U.